Home LiteratureArticle Details
PMID: 11678591 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.

Molecular and cellular biochemistry ·Vol. 222 ·No. 1-2 ·2001-06-00 ·Pages 107-18

Quievryn G, Goulart M, Messer J, Zhitkovich A

Abstract

The induction of genotoxicity by Cr (VI) is dependent on its reductive activation inside the cell. Our recent studies have found that reduction of Cr (VI) by cysteine resulted in the formation of mutagenic Cr (III)-DNA adducts in the absence of oxidative DNA damage. In this work, we examined the formation of oxidative and Cr (III)-dependent types of DNA damage under a broader range of Cr (VI) and cysteine concentrations and investigated a potential role of this reducer in intracellular metabolism of Cr (VI). Peripheral lymphocytes from unexposed humans had 7.8-fold excess of glutathione over cysteine, whereas lymphocytes from stainless steel welders contained only 3 times higher amount of glutathione (p = 0.0009) which was entirely caused by the decrease in the concentration of glutathione. A strong correlation (r = 0.72) between the levels of both thiols was found in lymphocytes from controls. The number of DNA-protein crosslinks in lymphocytes from welders was 4.1 times higher than among controls, indicating the presence of Cr (VI)-dependent DNA damage. The average rate of Cr (VI) reduction by cysteine was approximately 5 times faster than that by glutathione. Higher reduction rate combined with the decrease in the intracellular concentration of glutathione should make cysteine a predominant Cr (VI)-reducing thiol in lymphocytes of welders. Analysis of the initial rates of Cr (VI) reduction by different concentrations of cysteine suggested the presence of one- and two-electron pathways, with one-electron mechanism dominating in the physiological range of concentrations. There was no detectable formation of DNA breaks or abasic sites under a broad range of Cr (VI) and cysteine concentrations, resulting in up to 68-fold differences in the rates of reduction and the production of as many as 3 Cr (III)-DNA adducts per 10 bp. The reactions with slow reduction rates (low concentrations of cysteine) led to the most extensive formation of Cr (III)-DNA adducts. In summary, these results further establish Cr (III)-DNA adducts as the major form of DNA damage resulting from Cr (VI) metabolism by cysteine. The role of cysteine in reduction of Cr (VI) becomes more significant under conditions of occupational exposure to Cr (VI)-containing welding fumes.

MeSH Terms
Chromium/metabolism Cysteine/blood,metabolism DNA Adducts/metabolism DNA Damage/physiology Fluoresceins/metabolism Glutathione/blood,metabolism Humans Kinetics Lymphocytes/metabolism Male Oxidation-Reduction
Chemicals
DNA Adducts Fluoresceins Chromium chromium hexavalent ion 2',7'-dichlorofluorescein Glutathione Cysteine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Quievryn G
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.
Goulart M
Messer J
Zhitkovich A
References (35)
35 references, click to expand
  1. Hypervalent chromium mimics reactive oxygen species as measured by the oxidant-sensitive dyes 2',7'-dichlorofluorescin and dihydrorhodamine.
    Chem Res Toxicol. 1998 Dec;11(12 ):1402-10 PMID: 9860481
  2. Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds.
    Cancer Res. 1987 Apr 15;47(8):2142-7 PMID: 3829003
  3. Lung cancer mortality in nickel/chromium platers, 1946-95.
    Occup Environ Med. 1998 Apr;55(4):236-42 PMID: 9624277
  4. Loss of DNA-protein crosslinks from formaldehyde-exposed cells occurs through spontaneous hydrolysis and an active repair process linked to proteosome function.
    Carcinogenesis. 2000 Aug;21(8):1573-80 PMID: 10910961
  5. Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals.
    Chem Res Toxicol. 1994 Mar-Apr;7(2):219-30 PMID: 8199312
  6. Role of free radicals in metal-induced carcinogenesis.
    Met Ions Biol Syst. 1999;36:445-83 PMID: 10093933
  7. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports.
    Am J Ind Med. 1990;17(2):189-215 PMID: 2405656
  8. Analysis of DNA-protein complexes induced by chemical carcinogens.
    J Cell Biochem. 1990 Nov;44(3):127-35 PMID: 1702790
  9. Chromate-mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid hydroperoxides.
    Biochim Biophys Acta. 1994 Apr 12;1226(1):65-72 PMID: 8155741
  10. Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines.
    Cancer Res. 1986 Sep;46(9):4547-51 PMID: 3731109
  11. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
    Carcinogenesis. 1999 Jul;20(7):1267-75 PMID: 10383900
  12. Chromium as an industrial carcinogen: Part I.
    Am J Ind Med. 1997 Feb;31(2):129-39 PMID: 9028428
  13. Specific nicking of DNA at apurinic sites by peptides containing aromatic residues.
    J Biol Chem. 1981 Oct 25;256(20):10217-20 PMID: 6793576
  14. Metal carcinogenesis: mechanistic implications.
    Pharmacol Ther. 1992;53(1):31-65 PMID: 1641401
  15. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells.
    Nucleic Acids Res. 1998 Apr 15;26(8):2024-30 PMID: 9518499
  16. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
    Biochemistry. 2001 Jan 16;40(2):549-60 PMID: 11148050
  17. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung.
    Arch Toxicol. 1990;64(3):169-76 PMID: 2372230
  18. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts.
    Cancer Res. 1990 Dec 15;50(24):7835-42 PMID: 2253225
  19. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle.
    Carcinogenesis. 1996 Jul;17(7):1511-7 PMID: 8706257
  20. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
    Chem Res Toxicol. 2000 Nov;13(11):1114-24 PMID: 11087433
  21. Induction of mutagenic DNA damage by chromium (VI) and glutathione.
    Environ Mol Mutagen. 1996;28(2):71-9 PMID: 8844987
  22. Oxidative damage of DNA by chromium(V) complexes: relative importance of base versus sugar oxidation.
    Nucleic Acids Res. 1999 May 15;27(10):2219-26 PMID: 10219096
  23. Thiol status and cytopathological effects of acrolein in normal and xeroderma pigmentosum skin fibroblasts.
    Carcinogenesis. 1993 May;14(5):975-80 PMID: 8504492
  24. Differential binding of chromium(VI) and chromium(III) complexes to salmon sperm nuclei and nuclear DNA and isolated calf thymus DNA.
    Carcinogenesis. 1993 Sep;14(9):1795-803 PMID: 8403202
  25. Analysis of the induction of alkali sensitive sites in the DNA by chromate and other agents that induce single strand breaks.
    Carcinogenesis. 1984 Sep;5(9):1207-9 PMID: 6467509
  26. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group.
    Biochemistry. 1996 Jun 4;35(22):7275-82 PMID: 8679557
  27. Elevated DNA single-strand breakage frequencies in lymphocytes of welders exposed to chromium and nickel.
    Carcinogenesis. 1998 Mar;19(3):413-8 PMID: 9525274
  28. Clastogenicity and mutagenicity of hexavalent chromium in lacZ transgenic mice.
    Toxicol Lett. 1997 May 16;91(3):229-33 PMID: 9217243
  29. Chromium(V)-induced cleavage of DNA: are chromium(V) complexes the active carcinogens in chromium(VI)-induced cancers?
    Chem Res Toxicol. 1989 Jul-Aug;2(4):227-9 PMID: 2519778
  30. Novel reagents for chemical cleavage at abasic sites and UV photoproducts in DNA.
    Nucleic Acids Res. 1995 May 25;23(10):1664-70 PMID: 7784169
  31. Utilization of DNA-protein cross-links as a biomarker of chromium exposure.
    Environ Health Perspect. 1998 Aug;106 Suppl 4:969-74 PMID: 9703480
  32. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate.
    Carcinogenesis. 1995 Apr;16(4):907-13 PMID: 7728973
  33. A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo.
    Carcinogenesis. 1992 Aug;13(8):1485-9 PMID: 1499101
  34. Cr(IV) causes activation of nuclear transcription factor-kappa B, DNA strand breaks and dG hydroxylation via free radical reactions.
    J Inorg Biochem. 1999 May 30;75(1):37-44 PMID: 10402675
  35. Formation of modified cleavage termini from the reaction of chromium(V) with DNA.
    J Inorg Biochem. 1999 Nov-Dec;77(3-4):177-83 PMID: 10643657
Article Info
Journal
Molecular and cellular biochemistry
Abbr.
Mol Cell Biochem
ISSN
0300-8177
Published
2001-06-00
Pages
107-18
Language
English
Region
Netherlands
NLM ID
0364456
Subset
IM
Grants
NIEHS NIH HHS · R01 ES008786 · United States
NIEHS NIH HHS · ES08786 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]